Children’s Tumor Foundation President Annette Bakker was recently published in Fortune, writing about how platform clinical trials are speeding up the development of treatments for Covid-19, and that it should be the standard for all drug development, including for rare disease and cancer. Among the examples she lists, she highlights the work the Children’s Tumor Foundation is doing in NF to accelerate research for patients, including the INTUITT – NF2 platform trial. While a completely different disease area, the principles we are arguing for are the same – no matter the disease, get treatments to patients as quickly as possible! Click here to read the article.
